BRANT BALTHAZOR: Open Payments
NPI 1548640774 · SHEBOYGAN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,518 in 79 payments from 19 companies in 2025. Trend: 2023 $369 · 2024 $1,544 · 2025 $2,518
Food & beverage: $2,188Travel & lodging: $330
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $855 |
| Collegium Pharmaceutical, Inc. | 15 | $236 |
| ABBVIE INC. | 9 | $199 |
| IBSA Pharma Inc. | 10 | $137 |
| Boston Scientific Corporation | 1 | $136 |
| PFIZER INC. | 7 | $128 |
| SPR Therapeutics, Inc | 2 | $125 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $98 |
Products named: PROCLAIM, Belbuca, QULIPTA, Tirosint, Intracept, ETERNA, NURTEC ODT, SPRINT PNS System.
Industry payments across WI — which companies pay providers there.
